Platelets in vascular injury repair
Platelets in vascular injury repair
批准号:
10560637
负责人:
JOHN HWA
金额:
$56.39万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-02-15 至 2025-01-31
关键词:
AddressAffectAngioplastyAntiplatelet DrugsApoptosisArterial InjuryAspirinAutopsyBiometryBlood PlateletsBlood VesselsBypassCardiovascular DiseasesCardiovascular systemCell CommunicationCell ProliferationCellular biologyCoculture TechniquesComplexDevicesDiabetes MellitusDiabetic mouseDiseaseDoctor of PhilosophyDoseEndocytosisEndotheliumEquilibriumEventExhibitsExposure toFemurHemostatic functionHumanHyperplasiaIn VitroInflammationInjuryInterventionLiteratureMediatingMediatorMicroRNAsMusOperative Surgical ProceduresPatientsPharmaceutical PreparationsPhenotypePlatelet ActivationPlatelet-Derived Growth FactorPlayPositioning AttributeProceduresProcessProliferatingProstaglandins IRecoveryRegulationReporterResolutionRoleSamplingSecondary PreventionSiteSmooth Muscle MyocytesStentsSurgical complicationThrombosisThromboxanesTraumaVascular Smooth Musclecell dedifferentiationcell typediabeticdiabetic patientexperiencegenome-widein vivoinhibitorinjury and repairinsightmiRNA expression profilingmouse modelnew therapeutic targetnovelpreventprogramsrepairedrestenosistherapeutic targetuptakevascular injury
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Percutaneous arterial interventions and arterial bypass surgeries are complicated by the problem of intimal
hyperplasia (restenosis). Diabetic patients are more likely to experience restenosis, even after drug-eluting
stents. With ever increasing numbers of intravascular (e.g. angioplasty and insertion of devices) and
surgical procedures (e.g. bypass) for highly prevalent cardiovascular diseases, optimal resolution of repair
is essential. The process of arterial repair after injury is complex. Initiation of repair after injury is well
studied with thrombosis followed by inflammation, cellular proliferation and remodeling. Resolution of the
repair process is poorly understood, particularly, what constitutes the “brake” to prevent excessive repair?
Platelets provide a first and crucial line of defense against vascular injury, initially maintaining hemostasis.
Upon activation, platelets also release bioactive mediators such as PDGF and thromboxane, promoting
VSMC dedifferentiation from a quiescent contractile phenotype to a highly synthetic and proliferating cell
type, promoting injury repair. Excessive repair, such as observed with intimal hyperplasia in diabetes
mellitus (DM) after surgical or vascular interventions, can result from enhanced VSMC dedifferentiation and
proliferation. We will address the hypothesis that horizontal transfer of platelet-derived miRNAs into VSMCs
provide a novel mechanism for regulating VSMC phenotypic switching, preventing excessive repair and
intimal hyperplasia. We are in a unique position to address our hypothesis with recognized surgical
expertise in vascular surgical interventions and VSMC biology (Alan Dardik MD and Kathleen Martin PhD),
platelet expertise (John Hwa MD PhD, Wai Ho Tang PhD), and diabetes mellitus (Silvio Inzucchi MD,
Raimund Herzog MD). In the short term we will have presented a novel mechanism for platelet-VSMC
interaction and arterial injury repair. In the long term, these mechanistic insights may provide new
therapeutic targets in promoting arterial injury repair.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Platelets in vascular injury repair
-
批准号:10328958
-
项目类别:
-
资助金额:$56.39万
-
财政年份:2020
-
负责人:JOHN HWA
-
依托单位:
Yale Cooperative Center of Excellence in Hematology
-
批准号:10677840
-
项目类别:
-
资助金额:$81.38万
-
财政年份:2015
-
负责人:JOHN HWA
-
依托单位:
Platelet mitochondrial function in health and disease
-
批准号:9884665
-
项目类别:
-
资助金额:$50.58万
-
财政年份:2015
-
负责人:JOHN HWA
-
依托单位:
Platelet mitochondrial function in health and disease
-
批准号:10088457
-
项目类别:
-
资助金额:$50.58万
-
财政年份:2015
-
负责人:JOHN HWA
-
依托单位:
Platelet Mitochondrial Function in Health and Disease
-
批准号:8817070
-
项目类别:
-
资助金额:$41.63万
-
财政年份:2015
-
负责人:JOHN HWA
-
依托单位:
Platelet mitochondrial function in health and disease
-
批准号:10390280
-
项目类别:
-
资助金额:$50.58万
-
财政年份:2015
-
负责人:JOHN HWA
-
依托单位:
Platelet mitochondrial function in health and disease
-
批准号:10600123
-
项目类别:
-
资助金额:$50.58万
-
财政年份:2015
-
负责人:JOHN HWA
-
依托单位:
Platelet Mitochondrial Function in Health and Disease
-
批准号:9243286
-
项目类别:
-
资助金额:$41.63万
-
财政年份:2015
-
负责人:JOHN HWA
-
依托单位:
Platelet Mitochondrial Function in Health and Disease
-
批准号:9041675
-
项目类别:
-
资助金额:$41.63万
-
财政年份:2015
-
负责人:JOHN HWA
-
依托单位:
Hyperglycemia, thromboxane and platelet activity in diabetes mellitus
-
批准号:8344530
-
项目类别:
-
资助金额:$41.51万
-
财政年份:2012
-
负责人:JOHN HWA
-
依托单位:
Hyperglycemia, aldose reductase, miRNA and cardiovascular disease in diabetes mellitus
-
批准号:9334914
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2012
-
负责人:JOHN HWA
-
依托单位:
Hyperglycemia, aldose reductase, miRNA and cardiovascular disease in diabetes mellitus
-
批准号:9481394
-
项目类别:
-
资助金额:$7.15万
-
财政年份:2012
-
负责人:JOHN HWA
-
依托单位:
Hyperglycemia, thromboxane and platelet activity in diabetes mellitus
-
批准号:8516093
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2012
-
负责人:JOHN HWA
-
依托单位:
Hyperglycemia, thromboxane and platelet activity in diabetes mellitus
-
批准号:8895384
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2012
-
负责人:JOHN HWA
-
依托单位:
Hyperglycemia, aldose reductase, miRNA and cardiovascular disease in diabetes mellitus
-
批准号:9182509
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2012
-
负责人:JOHN HWA
-
依托单位:
Hyperglycemia, thromboxane and platelet activity in diabetes mellitus
-
批准号:8701381
-
项目类别:
-
资助金额:$40.79万
-
财政年份:2012
-
负责人:JOHN HWA
-
依托单位:
Pharmacogenetics of the human prostacyclin receptor.
-
批准号:8206742
-
项目类别:
-
资助金额:$40.96万
-
财政年份:2004
-
负责人:JOHN HWA
-
依托单位:
Pharmacogenetics of the human prostacyclin receptor.
-
批准号:7755853
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2004
-
负责人:JOHN HWA
-
依托单位:
Pharmacogenetics of the human prostacyclin receptor
-
批准号:7219404
-
项目类别:
-
资助金额:$30.32万
-
财政年份:2004
-
负责人:JOHN HWA
-
依托单位:
Pharmacogenetics of the human prostacyclin receptor.
-
批准号:7036600
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2004
-
负责人:JOHN HWA
-
依托单位:
海外基金